Abbott India Ltd

500488

Summary

Fair Value Assessment
Overvalued (37% Premium)
Fair ValueQ21,546.54UncertaintyVery High
Close Price29,609.30Mar 13, 2025
Market Closed
29,609.30
Price Down by 213.50 | 0.72 %
Previous Close
29,609.30
Day Range
29,536.95 – 30,109.75
Year Range
25,200.05 – 31,900.00
Bid / Ask
Market Cap
629.2 Bil
Volume / Average
387.0 / 581.1
Beta (5-Year)
0.15
Shares Outstanding
21.25 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
Contact
Plot C-68, G Block 16th Floor, Godrej BKC, Mumbai, MH 400051
T +91 2250461000
www.abbott.co.in opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
3,878

Key Metrics

Income Statement (in Bil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
62.41 58.47 53.47 49.10 43.08 40.91
Revenue Growth %
8.52% 9.36% 8.89% 13.99% 5.30% 11.31%
Gross Profit
27.83 26.15 23.63 22.43 19.10 17.67
Gross Profit Margin %
44.59% 44.72% 44.19% 45.68% 44.34% 43.18%
Operating Income
15.47 14.06 11.47 10.26 8.72 7.05
Operating Margin %
24.79% 24.04% 21.46% 20.90% 20.25% 17.24%
EBIT
15.80 14.06 11.46 10.23 8.65 6.98
EBIT Margin %
25.32% 24.05% 21.43% 20.83% 20.07% 17.06%
EBITDA
16.52 14.77 12.16 10.89 9.23 7.58
EBITDA Margin %
26.47% 25.27% 22.74% 22.18% 21.42% 18.52%
Net Income
13.34 12.01 9.49 7.99 6.91 5.93
Net Profit Margin %
21.38% 20.54% 17.76% 16.27% 16.03% 14.49%
Basic EPS
627.98 565.28 446.78 375.86 325.04 279.04
Diluted EPS
627.98 565.28 446.78 375.86 325.04 279.04
Normalized EPS
632.94 569.29 448.59 382.06 325.51 283.11
Total Dividends per Share
410.00 325.00 275.00 275.00 250.00 65.00
Balance Sheet (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
50.63 51.93 45.56 42.24 38.40 35.47
Total Liabilities
15.42 14.95 13.67 14.04 12.38 11.15
Total Debt
0.61 0.83 1.13 1.52 1.53 1.75
Total Equity
35.21 36.99 31.89 28.20 26.02 24.32
Cash And Cash Equivalents
6.38 2.92 2.40 1.33 2.18 1.45
Working Capital
17.24 19.03 18.19 26.50 24.88 23.14
Shares Outstanding (Bil)
0.02 0.02 0.02
Book Value Per Share
1,721.81 1,480.53 1,306.22 1,203.75 1,127.54
Total Debt To Equity
0.02 0.02 0.04 0.05 0.06 0.07
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
10.11 12.13 8.93 9.48 7.27 6.26
Cash From Investing Activities
-0.26 -4.16 -1.48 -3.96 -0.72 -4.01
Cash From Financing Activities
-9.26 -7.45 -6.39 -6.37 -5.82 -2.17
Capital Expenditures
0.48 0.34 0.44 0.23 0.16
Free Cash Flow
10.35 8.36 7.74 6.92 5.40
Change in Cash
0.60 0.52 1.07 -0.86 0.73 0.08

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

Name
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Change Amount
Change %
Date
SBI Large & Midcap Reg IDCW-P 1.29 3.05 274,878
Feb 28, 2025
Axis Midcap Gr 0.77 1.91 164,230
Feb 28, 2025
Canara Robeco Emerging Eqs Reg Gr 0.72 2.17 152,795
-1,097
0.71%
Feb 28, 2025
SBI Magnum Global Reg IDCW-P Not Rated 0.47 5.21 100,000
Feb 28, 2025
Nippon India Pharma Gr Not Rated 0.45 3.82 95,985
9,595
11.11%
Feb 28, 2025
Total (for Top 5) 3.71 787,888
8,498

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top